comlogo01.svg comlogo01.svg

ENDPOINTS NEWS | Trailing Novartis and Eli Lilly, radiopharmaceuticals startup Full-Life Technologies nabs $63M to test new PSMA drug

Jan 22, 2024
Previous
Back to list
Next
Contact Media Relations

For the Media

We welcome media inquiries. Please indicate your deadline on the subject line.

pr@t-full.com